Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Organigram Global Inc. (OGI : NSDQ)

• Company Description    Organigram Global Inc. is focused on producing cannabis for adult recreational consumers. Organigram Global Inc., formerly known as OrganiGram Holdings Inc, is based in TORONTO. Number of Employees: 1,139

• Price / Volume Information    Yesterday's Closing Price: $1.29 Daily Weekly Monthly 20 Day Moving Average: 721,339 shares Shares Outstanding: 135.13 (millions) Market Capitalization: $174.32 (millions) Beta: 1.60 52 Week High: $2.24 52 Week Low: $0.85 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -19.88% -18.66% 12 Week -12.84% -15.81% Year To Date -23.21% -23.11%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1400-145 King Street West - Toronto,A6 M5H 1J8 CAN ph: 1-844-644-4726 fax: - None http://www.organigram.ca

• General Corporate Information    Officers Beena Goldenberg - Chief Executive Officer Peter Amirault - Chairman Greg Guyatt - Chief Financial Officer Nathalie Batten Kubrick - Senior Vice President of Operations Max Schwartz - Director Peer Information Organigram Global Inc. (BJCT) Organigram Global Inc. (CADMQ) Organigram Global Inc. (APNO) Organigram Global Inc. (UPDC) Organigram Global Inc. (IMTIQ) Organigram Global Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 68617J100 SIC: 2834 Fiscal Year Fiscal Year End: September Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/11/26 Share - Related Items Shares Outstanding: 135.13 Most Recent Split Date: 7.00 (0.25:1) Beta: 1.60 Market Capitalization: $174.32 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.00 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.09 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/11/26

• Fundamental Ratios P/E Current FY Estimate: 14.89 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.66 Price/Cash Flow: - Price / Sales: 0.87 EPS Growth vs. Year Ago Period: 60.00% vs. Previous Quarter: 90.00% Sales Growth vs. Year Ago Period: 49.24% vs. Previous Quarter: -19.91% ROE 12/31/25 - -15.41 09/30/25 - -16.91 06/30/25 - -8.19 ROA 12/31/25 - -10.49 09/30/25 - -11.43 06/30/25 - -5.79 Current Ratio 12/31/25 - 2.73 09/30/25 - 2.26 06/30/25 - 2.59 Quick Ratio 12/31/25 - 1.32 09/30/25 - 1.28 06/30/25 - 1.42 Operating Margin 12/31/25 - -20.59 09/30/25 - -23.66 06/30/25 - -12.87 Net Margin 12/31/25 - 6.03 09/30/25 - -9.99 06/30/25 - 2.86 Pre-Tax Margin 12/31/25 - 1.59 09/30/25 - -14.86 06/30/25 - -1.50 Book Value 12/31/25 - 1.96 09/30/25 - 1.86 06/30/25 - 2.08 Inventory Turnover 12/31/25 - 1.46 09/30/25 - 1.45 06/30/25 - 1.38 Debt-to-Equity 12/31/25 - 0.00 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - 12.96 09/30/25 - 16.43 06/30/25 - 10.41

Powered by Zacks Investment Research ©